Moraes Diogo de, Mousovich-Neto Felippe, Cury Sarah Santiloni, Oliveira Jakeline, Souza Jeferson Dos Santos, Freire Paula Paccielli, Dal-Pai-Silva Maeli, Mori Marcelo Alves da Silva, Fernandez Geysson Javier, Carvalho Robson Francisco
Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University, UNESP, Botucatu 18618-689, SP, Brazil.
Department of Biochemistry and Tissue Biology, University of Campinas, Monteiro Lobato St., 255, Campinas 13083-862, SP, Brazil.
Biomedicines. 2023 May 14;11(5):1446. doi: 10.3390/biomedicines11051446.
Aging causes alterations in body composition. Specifically, visceral fat mass increases with age and is associated with age-related diseases. The pathogenic potential of visceral fat accumulation has been associated with its anatomical location and metabolic activity. Visceral fat may control systemic metabolism by secreting molecules that act in distal tissues, mainly the liver, through the portal vein. Currently, little is known about age-related changes in visceral fat in humans. Aiming to identify molecular and cellular changes occurring with aging in the visceral fat of humans, we analyzed publicly available transcriptomic data of 355 omentum samples from the Genotype-Tissue Expression portal (GTEx) of 20-79-year-old males and females. We identified the functional enrichment of genes associated with aging, inferred age-related changes in visceral fat cellularity by deconvolution analysis, profiled the senescence-associated secretory phenotype of visceral adipose tissue, and predicted the connectivity of the age-induced visceral fat secretome with the liver. We demonstrate that age induces alterations in visceral fat cellularity, synchronous to changes in metabolic pathways and a shift toward a pro-inflammatory secretory phenotype. Furthermore, our approach identified candidates such as , and to mediate visceral fat-liver crosstalk in the context of aging. These findings cast light on how alterations in visceral fat with aging contribute to liver dysfunction and age-related disease etiology.
衰老会导致身体成分发生改变。具体而言,内脏脂肪量会随着年龄增长而增加,并与年龄相关疾病有关。内脏脂肪堆积的致病潜力与其解剖位置和代谢活性相关。内脏脂肪可能通过分泌经门静脉作用于远端组织(主要是肝脏)的分子来控制全身代谢。目前,关于人类内脏脂肪与年龄相关的变化知之甚少。为了确定人类内脏脂肪随衰老发生的分子和细胞变化,我们分析了来自基因型-组织表达数据库(GTEx)的355份20至79岁男性和女性网膜样本的公开转录组数据。我们确定了与衰老相关基因的功能富集情况,通过反卷积分析推断内脏脂肪细胞数量与年龄相关的变化,描绘了内脏脂肪组织衰老相关分泌表型,并预测了年龄诱导的内脏脂肪分泌组与肝脏的连接性。我们证明,年龄会诱导内脏脂肪细胞数量发生改变,这与代谢途径的变化以及向促炎分泌表型的转变同步。此外,我们的方法确定了如[此处原文缺失具体基因名称]等候选基因,以介导衰老背景下内脏脂肪与肝脏的相互作用。这些发现揭示了内脏脂肪随衰老发生的改变如何导致肝功能障碍和年龄相关疾病的病因。